NASDAQ:COYA | Free Cash Flow | Coya Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.21M
2025-12-31-$1.01M
2025-03-31-$2.83M
2024-12-31-$2.41M
2024-03-31$2.15M
2023-12-31-$2.24M
2023-03-31-$3.86M
2022-12-31-$2.22M
2022-03-31-$1.98M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.74M
2024-12-31-$10.29M
2023-12-31-$11.19M
2022-12-31-$7.24M
2021-12-31-$3.9M